Hematopoietic growth factor therapy of myelodysplastic syndromes

Leuk Lymphoma. 1993:11 Suppl 2:65-9. doi: 10.3109/10428199309064264.

Authors

A G Arcenas¹, S Vadhan-Raj

Affiliation

¹ Department of Clinical Immunology and Biological Therapy, University of Texas M.D. Anderson Cancer Center, Houston 77030.

PMID: 7510197
DOI: 10.3109/10428199309064264

No abstract available

Publication types

Review

MeSH terms

Clinical Trials as Topic
Erythropoietin / therapeutic use
Granulocyte Colony-Stimulating Factor / therapeutic use
Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
Hematopoietic Cell Growth Factors / therapeutic use*
Humans
Interleukin-3 / therapeutic use
Interleukin-6 / therapeutic use
Myelodysplastic Syndromes / therapy*

Substances

Hematopoietic Cell Growth Factors
Interleukin-3
Interleukin-6
Erythropoietin
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor